Nu se compensează tratamentul cu Oxaliplatinum pentru cancerul de colon stadiul II (Dukes B) şi tratamentul adjuvant al pacienţilor cu cancer rectal.
________________________________________________________________________________
______________________________________________________________________________
| 742 |L01XC04| ALEMTUZUMABUM**** | Protocol: L024C |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
L01XC04 ALEMTUZUMABUM CONC. PT. SOL. PERF. 10 mg/ml
MABCAMPATH 10 mg/ml 10 mg/ml GENZYME EUROPE BV
L01XC04 ALEMTUZUMABUM CONC. PT. SOL. PERF. 30 mg/ml
MABCAMPATH 30 mg/ml 30 mg/ml GENZYME EUROPE BV
________________________________________________________________________________
______________________________________________________________________________
| 743 |L01XC02| RITUXIMABUM**** | Protocol: L014C |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
L01XC02 RITUXIMABUM CONC. PT. SOL. PERF. 10 mg/ml
MABTHERA 100 mg 10 mg/ml ROCHE REGISTRATION LTD.
MABTHERA 500 mg 10 mg/ml ROCHE REGISTRATION LTD.
L01XC02 RITUXIMABUM CONC. PT. SOL. PERF. 10 mg/ml
MABTHERA 100 mg 10 mg/ml ROCHE REGISTRATION LTD.
MABTHERA 500 mg 10 mg/ml ROCHE REGISTRATION LTD.
________________________________________________________________________________
______________________________________________________________________________
| 744 |L01XC03| TRASTUZUMABUM**** | Protocol: L026C |
|_______|_______|____________________________________________|_________________|
NOTĂ:
Dostları ilə paylaş: | 
